As antimicrobial resistance (AMR) intensifies globally, vaccines and antimicrobial resistance are now closely linked in public health strategies. Vaccines can reduce infections that often require antibiotics, thereby lowering unnecessary antimicrobial use and slowing the spread of resistant strains. Pneumococcal, typhoid, and influenza vaccines have already demonstrated indirect impacts on resistance trends. New vaccine targets for resistant pathogens like Klebsiella, Pseudomonas, and MRSA are under investigation. Incorporating vaccines into AMR mitigation policies could reduce dependence on antibiotics across healthcare and agricultural sectors. Integrating surveillance data from both fields is enhancing policy design and research priorities. Vaccines and antimicrobial resistance intersect as part of a holistic response to preserving drug efficacy and safeguarding future generations.
Title : The importance of post-marketing surveillance and real-world data: For a product to be successful
Regina Au, BioMarketing Insight, United States
Title : A promising novel approach to DNA vaccines
Khursheed Anwer, IMUNON, United States
Title : Prophylactic and molecular approaches for mitigating human influenza A viruses: i. Evaluating influenza vaccine effectiveness in the older population ii. Down-regulation of influenza virus genes with novel sirna-chimeric-ribozyme constructs
Madhu Khanna, University of Delhi, India
Title : Post COVID-19 syndrome is associated with sex and severity of first COVID-19 episode in Honduras
Manuel Antonio Sierra Santos, Central American Technological University, Honduras
Title : Homology analysis of MPXV and VACV peptides underscores the need to consider both MPXV clades for vaccine development
Lara Isis Teodoro, Mayo Clinic, United States
Title : Establishing a platform method for physical appearance assessment of new parenteral pharmaceuticals
Ying Wan, Merck & Co., United States
Title : Development of a novel multi-component vaccine to address the burden of otitis media in high-risk populations
Ayesha Zahid, Griffith University, Australia
Title : High seroprevalence of RSV antibodies in adults indicates potential undetected transmission and requires further public health assessment
Lara Isis Teodoro, Mayo Clinic, United States
Title : New biomarkers in leishmania major vaccine development
Negar Seyed, Pasteur Institute of Iran, Iran (Islamic Republic of)
Title : Development of a platform UPLC-CAD method for high-throughput lipid quantitation and characterization in novel mRNA LNPs
Janet Muzulu, Sanofi, United States